Expanding Pan-antiallergy Vaccine Technology to New Applications

This inventive concept explores the application of the pan-antiallergy vaccine technology to novel fields, including cancer treatment, agricultural worker safety, neurodegenerative disease management, food product safety, and cardiovascular disease prevention.

The original pan-antiallergy vaccine patent addressed a significant need in the field of immunology. However, its scope was limited to treating allergies. This new inventive concept addresses the problem of underutilization of the core technology by applying it to entirely new industries and fields, thereby expanding its impact and potential benefits.

The new claims describe various applications of the pan-antiallergy vaccine technology. For instance, the protein construct can be used to induce an immune response against IgE in cancer treatment, reducing the risk of allergic reactions in agricultural workers, enhancing the delivery of neuroprotective agents across the blood-brain barrier, detecting IgE levels in food products, and reducing IgE-mediated inflammation in cardiovascular disease. These new applications leverage the core technology's ability to modulate the immune system, offering innovative solutions to pressing problems in diverse fields.

The new claims introduce a non-obvious expansion of the original patent's scope, applying the pan-antiallergy vaccine technology to novel fields and industries. This inventive step lies in the recognition of the technology's potential to address unmet needs beyond its original intended use.

Alternative embodiments of this inventive concept could include modifying the protein construct to target specific IgE subtypes, developing novel adjuvants or delivery mechanisms, or exploring combination therapies with existing treatments. Variations could also involve applying the technology to other diseases or conditions where IgE modulation is beneficial.

This inventive concept has significant commercial potential, with applications in the pharmaceutical, agricultural, and food industries. The market for these new applications is substantial, with potential users including cancer treatment centers, agricultural companies, neurology clinics, food manufacturers, and cardiovascular disease treatment providers.